Skip to main content
Oxurion NV logo

Oxurion NV — Investor Relations & Filings

Ticker · OXUR ISIN · BE0974487192 LEI · 549300VWY8KVDFKLDM59 BR Professional, scientific and technical activities
Open in API
Filings indexed 1,031 across all filing types
Latest filing 2023-09-18 Major Shareholding Noti…
Country BE Belgium
Listing BR OXUR

About Oxurion NV

https://oxurion.com/

Oxurion NV is a company focused on acquiring majority stakes in European pharmaceutical subcontractors. Its strategy is to build an integrated group of contract service providers to support healthcare stakeholders. A key asset in its portfolio is a majority stake in Axiodis CRO, a contract research organization specializing in biometrics. This investment-based business model represents a strategic pivot from the company's former focus on the internal research and development of therapies for retinal diseases such as Geographic Atrophy (GA) and Age-related Macular Degeneration (AMD).

Recent filings

Filing Released Lang Actions
oxur-transparency-notification-nl-20230918-final.pdf
Major Shareholding Notification Classification · 100% confidence The document is a press release from Oxurion NV announcing the receipt of transparency notifications regarding changes in shareholding by Atlas Special Opportunities LLC. It explicitly mentions crossing and falling below the 3% threshold of voting rights, which is a classic 'Major Shareholding Notification' (also known as a transparency notification). The document includes the formal TR-1 forms as attachments, confirming the nature of the disclosure.
2023-09-18 English
Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas (15).pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas" and explicitly states it is "Regulated Information - Denominator". It details a capital increase resulting from the conversion of convertible bonds and updates the total number of outstanding ordinary shares carrying voting rights (the denominator). This type of announcement, which reports on changes in the total share count used for calculating ownership percentages, is a specific type of corporate action disclosure. While it relates to capital structure, its primary function here is to update the official share count denominator as required by market regulations (Article 15 of the Belgian Act mentioned). This fits best under Capital/Financing Update (CAP) as it directly results from a financing event (bond conversion leading to capital increase), or potentially Regulatory Filings (RNS) if a more specific code isn't available. Given the focus on the capital increase and the resulting share count update, CAP is a strong candidate. However, the core content is the mandatory disclosure of the total voting rights denominator following a transaction. Since the definitions do not explicitly cover 'Denominator Disclosure', I must choose the closest fit. The event is a direct result of a financing/capital commitment execution. Let's re-evaluate the options: 'CAP' (Capital/Financing Update) covers fundraising/capital structure changes. 'SHA' (Share Issue/Capital Change) covers new share issues. Since this is a direct consequence of a capital increase via bond conversion, SHA is highly relevant. The document explicitly states the issuance of new ordinary shares and the resulting total number of shares. Therefore, SHA (Share Issue/Capital Change) is the most precise fit for reporting the final share count after an issuance event.
2023-09-18 English
oxur-pr-voting-rights-ned-20230915.pdf
Share Issue/Capital Change Classification · 99% confidence The document is titled 'Informatie met betrekking tot het Totaal Aantal Stemrechten (Noemer)' and explicitly states that it is publishing updated information regarding the total number of voting rights following a capital increase due to bond conversion. It cites Article 15 of the Belgian law concerning the disclosure of major shareholdings. The core content is the calculation and announcement of the new total number of outstanding shares (the denominator) used for ownership percentage calculations. This type of mandatory disclosure, focusing on the total number of voting rights/shares, is a specific regulatory filing related to share capital structure changes and major shareholding thresholds, but it is not a full financial report (10-K or IR). Since it is a specific regulatory announcement detailing changes in the share base used for ownership calculations, it fits best under the category for notifications related to significant share ownership changes or general regulatory announcements. Given the focus on the 'Noemer' (denominator) and the reference to disclosure laws regarding major shareholdings, it is closely related to 'Major Shareholding Notification' (MRQ) or a general 'Regulatory Filing' (RNS). However, the content is specifically about updating the total share count (the denominator) after a capital event, which is a prerequisite for major shareholding notifications. Since the document itself is a formal press release announcing this specific regulatory metric update, and it doesn't fit perfectly into the other specific categories like DIV, CAP, or DIRS, the most appropriate general regulatory classification is RNS, although MRQ is also plausible if this update is always bundled with major shareholder changes. Given the explicit mention of the law on 'openbaarmaking van belangrijke deelnemingen' (disclosure of important shareholdings) and the calculation of the denominator, it is a direct regulatory disclosure. I will classify it as RNS as it is a general regulatory announcement detailing a key metric change, which is often the purpose of such press releases.
2023-09-18 Dutch
PR Oxurion Atlas KRP Amendment ENG.pdf
Capital/Financing Update Classification · 99% confidence The document is a press release dated September 11, 2023, titled "Oxurion Announces Key Amendments to Atlas and Kreos/Pontifax Agreements Enabling KALAHARI Trial to Progress...". It details amendments to financing agreements (Convertible Bonds and Loan Agreement) involving specific monetary amounts and covenant changes. It also mentions the impact on a clinical trial (KALAHARI Trial) and includes quotes from the CEO. The text explicitly states it is 'Regulated Information – Inside Information'. This type of announcement, focusing on significant financing and operational updates outside of standard periodic financial reports (like 10-K or IR), best fits the 'Capital/Financing Update' category. It is not a full financial report, an earnings release, or a proxy statement. Given the focus on debt restructuring and new funding tranches, 'CAP' is the most appropriate classification.
2023-09-11 English
PR Oxurion Atlas KRP amendment NL.pdf
Capital/Financing Update Classification · 99% confidence The document is an announcement dated September 11, 2023, detailing amendments to financing agreements (Convertible Bond Agreement with Atlas and Loan Agreement with Kreos/Pontifax). It specifically mentions changes to financing terms, debt reduction, and the ability to proceed with the KALAHARI trial to topline results. This content directly relates to the company's fundraising, financing activities, and capital structure adjustments. Therefore, it fits the definition of 'Capital/Financing Update' (CAP). It is not a full annual report (10-K), an earnings release (ER), or a general regulatory filing (RNS), as it concerns specific financing actions.
2023-09-11 Dutch
OXUR PR_Voting rights (ENG)_20230907.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is explicitly titled as a "PRESS RELEASE" and contains the header "Regulated Information - Denominator". It details the 'Information on the Total Number of Voting Rights' following a capital increase due to bond conversion. This type of mandatory disclosure, which updates the total number of outstanding shares used as the denominator for calculating shareholdings, is a specific regulatory filing related to share capital and voting rights. While it involves capital changes (CAP) and share issuance (SHA), the primary focus and explicit regulatory context point towards a notification about the total number of shares/voting rights, which is often categorized under general regulatory announcements or specific share/capital change notifications. Given the options, this is a direct notification impacting the share structure and voting base. It is not a full 10-K, AR, or IR. It is a specific announcement regarding the share count, which aligns closely with 'Share Issue/Capital Change' (SHA) or a general 'Regulatory Filing' (RNS). Since the core content is the calculation of the denominator following a capital increase (issuance of 106,332,703 new ordinary shares), SHA is a strong candidate. However, the document explicitly states it is publishing the updated denominator as required by Belgian law (Article 15), which is a mandatory disclosure. In many filing taxonomies, specific denominator updates are often grouped under general regulatory disclosures or share/capital changes. Given the explicit mention of the resulting share count change, SHA is highly relevant, but the nature of the disclosure (Denominator update) often falls under general regulatory reporting. Since the document is a formal press release announcing a change in the total number of voting rights (the denominator) due to a capital increase, it fits best under a general regulatory announcement or a specific capital/share change. Let's re-evaluate the definitions. SHA is 'Share Issue/Capital Change'. This document announces the result of a capital increase (issuance of new shares) and the resulting total share count. This is a direct consequence and announcement of a capital change. Therefore, SHA is the most precise fit among the specific options related to capital structure changes. If SHA was not available, RNS would be the fallback. I will classify it as SHA due to the explicit announcement of the new total share count following the issuance of new shares.
2023-09-08 English

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.